arrow
P

Paul Costeas

centre for the study of haematological and other malignancies
H指数:24
被引数:2,539

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Case Report: Novel ASAP1::BRAF fusion in a young adult with low-grade temporal lobe glioma
2026-01-230
OAAI
A ROLE FOR ADAR1 IN THE RESISTANCE TO HYPOMETHYLATING AGENTS (HMA) IN HIGH-RISK MYELODYSPLASTIC SYNDROME (HR-MDS)

ADAR1在对抗低甲基化剂(HMA)方面的高危骨髓增生异常综合征(HR-MDS)中的作用

2025-09-010
PRE
THE ROLE OF THE ADENOSINERGIC PATHWAY IN THE RESPONSE TO AZACYTIDINE IN HR-MDS PATIENTS PROGNOSIS-PREDICTIVE FACTORS OF RESPONSE TO TREATMENT

腺苷能通路在AZACYTIDINE对HR-MDS患者反应中的作用——治疗反应的预后预测因素

2025-09-010
PRE
Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis

端粒损耗成为衰老造血和白血病发生过程中克隆选择的一种机制。

2025-08-280
OAAI
Polymeric micelles effectively reprogram the tumor microenvironment to potentiate nano-immunotherapy in mouse breast cancer models
2022-11-2251
OAAI
Pharmacological activation of the C5a receptor leads to stimulation of the β-adrenergic receptor and alleviates cognitive impairment in a murine model of familial Alzheimer's disease
2022-08-262
OAAI
Normalizing the Microenvironment Overcomes Vessel Compression and Resistance to Nano-immunotherapy in Breast Cancer Lung Metastasis

在乳腺癌肺转移中,使微环境正常化克服了血管压迫和对纳米免疫疗法的抵抗力

2020-12-1376
OAAI
TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity

Tgf-β 抑制剂联合细胞毒性纳米药物使三阴性乳腺癌微环境正常化,以抗肿瘤免疫

2020-01-01136
OAAI
Simple in vitro generation of human leukocyte antigen-G-expressing T-regulatory cells through pharmacological hypomethylation for adoptive cellular immunotherapy against graft-versus-host disease

通过药物低甲基化简单体外产生表达人类白细胞抗原G的T调节细胞,用于过继细胞免疫治疗移植物抗宿主病

2017-04-0114
PREAI
Treatment and outcome of 2904 CML patients from the EUTOS population-based registry
LEUKEMIA
IF13.4
2016-08-2976
PREAI